Abstract
Rationale of the trialAlthough the use of engineered T cells in cancer immunotherapy has greatly advanced the treatment of hematological malignancies, reaching meaningful clinical responses in the treatment of solid...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have